Through inducing immunogenic cell death (ICD) of cancer cells (Leonetti et al., 2019), chemotherapy can increase TILs and PD-L1 expression on tumor cells, and thereby synergize with anti-PD-1. This evidence concerns the gene PDCD1 and cancer.